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ABSTRACT 
Molecular docking study using chalcone analogue compounds with proteins target 
from modeling crystallographic structure of Tyrosine kinase enzymes with code 
1T46 was carried out with the aid of a computer using the AutoDock Vina program. 
The aim this study to determine the activity of 5 chalcone analogue compounds 
obtained from previous studies and 3 chalcone analogues which were modified as 
inhibitors of liver cancer using 5-fluorouracil as a positive control. Based on the 
docking results, it has been carried out and shown those compounds 1, 2, and 3 have 
the potential as the active inhibitors againts HepG2 liver cancer with a successive 
affinity of -10.1 kcal/mol, -9.7 kcal/mol, and - 9.6 kcal/mol, respectively. For the 
modified chalcone analogue compounds, compound 8 has the best results with an 
affinity value of -8.3 kcal/mol and this compound also has six amino acid residues 
which are the same as 5-flourouracyl (i.e. positive control). 
Keywords: chalcone, hepatocellular carcinoma, molecular docking, tyrosine kinase.   
 
1. INTRODUCTION 
 
Cancer is a disease characterized by uncontrolled growth and the spread of 
abnormal cells, these uncontrolled spread can cause death [1]. Lung, breast, 
stomach, colorectal, and liver cancers are the biggest cause of death every year [2].  
Statistical data in 2018 on the incidence of the liver cancer in USA based on sex, 
it is showed that for new cases ranked 10th and for cases of cancer death ranked 5th 
[3]. While the incidence of liver cancer in Indonesia by sex shows that for new cases 
it ranks 7th and for cases of death ranks 3rd [2]. 
There are several types of liver cancer treatment, namely chemotherapy, 
radiotherapy and surgery [4]. The side effects of cancer treatment using 
chemotherapy methods cause hair loss, nausea, vomiting, diarrhea, susceptibility to 
infection, thrombocytopenia, neuropathy, and myalgia while radiation causes the 
effects of nausea and vomiting, and surgery is not entirely able to remove damaged 
tissue due to cancer [5]. Base on these conditions, it is necessary to conduct a search 
for cytotoxic substances that have a potential to treat liver cancer [6]. One of the 
compounds used as liver cancer inhibitors is chalcone [7]. 
Chalcone compounds are flavonoid secondary metabolites which have a base 
skeleton of 1,3-diarylpropanoid which can be found in plants [8].  Chalcone has 
attracted a lot of attention because of the diversity of biological activities such as 
antiviral [9]. anti-inflammatory[ 10]. antibacterial [11]. antioxidants [12], 
antimalarial [13], and anticancer [14]. 
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Research to find active compounds for then these compounds can be used as liver 
cancer inhibitors is increasingly being carried out and the most widely used method 
is isolation and synthesis. But these two methods use complex equipment with 
relatively expensive reagents and to ensure the activity of a compound must be 
tested through invitro or invivo assay. Therefore, the insilico method with molecular 
docking technique was chosen to predict the activity of chalcone analogue 
compounds before laboratory experiments [15]. 
 Molecular docking has many advantages, such as it certainly reduce the use of 
solvents and chemicals that can pollute the environment, and also save costs. This 
method can also be used to predict the activity of compounds such as chalcone by 
calculating the bonding or energy affinity involved in the interaction with the protein 
active site. The category of active compounds are if there are interaction of chalcone 
with the protein, and it is only requires low energy and the interation have to bind 
with  the protein active site [15]. 
Study of molecular docking chalcone analogue compounds was carried out base 
on Mai et al (2014) [16]. However, so far there have not been many studies that have 
conducted insilico studies by modifying the structure of compounds. The purpose of 
this study was to determine the activity of 8 chalcone analogue compounds as 
inhibitors for liver cancer against enzyme residues on receptors and to compare the 
activity of some chalcone analogues with 5-fluorouracil drugs as liver anticancer. 
So, it can be used as an alternative medicine ingredient. 
2. METHODS 
2.1 TOOLS 
The tools used in this research is the Intel laptop Core i3-6006U, 2.0 GHz, 
dengan RAM 4 GB. Chemdraw Ultra 12.0 (CambridgeSoft), Discovery Studio 
Visualizer (BIOVIA), MGL Tools 1.5.6, AutoDock Tools 1.5.6, AutoDock Vina, dan 
PyMOL. 
 
2.2 MATERIAL 
 
The material used in this study is protein 1T46 which was downloaded from  
www.pdb.org in the GDP format. The ligand used is the 5-Fluorouracil structure, 5 
chalcone analogues that have been studied by Mai et al (2014) and 3 modified 
chalcone analogues shown in Table 1. 
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TABLE 1. 
Structure of Analogous Chalcone Compounds as Ligands 
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2.3 PROTEIN PREPARATION 
The water molecules are removed using DSV. Furthermore, hydrogen atoms are 
added using AutoDock Tools 1.5.6 and stored in PDBQT format. 
 
2.4 LIGAND PREPARATION 
 
The molecular structure of chalcone is drawn using Chemdraw Ultra 12.0 
(Cambridge), then save it in PDB format using DSV. Ligands in PDB format are 
inputted to the AutoDock Tools 1.5.6 program for further preparation. Rotating 
bonds can be corrected in the Torsion Tree panel for ligand flexible properties. Then 
the ligand is save in the PDBQT format. 
2.5 GRID BOX SETTINGS 
In AutoDock Tools 1.5.6, the grid menu is selected to open proteins that have 
been prepared in PDBQT format, then the grid box is created to determine the space 
in which the docking simulation will run. The size of the distance in the grid box is 
set to 1 Å and the dimensions of the x, y and z are arranged in such a way that the 
grid box can load the active side of the protein. In this study, the grid box is located 
at coordinates x: 31,925, y: 25,893, and z: 35,098. Grid box data will be needed to 
create configuration data. 
 
2.6 MAKING CONFIGURATION DATA 
 
Configuration data is created in the work folder in the form of a Text Document 
with the name ‘conf.txt 'and filled in according to the name of the protein that is the 
receptor and ligand in PDBQT format, followed by the dimensions and the position 
of the angles x, y and z in the grid box settings. 
2.7 DOCKING SIMULATION USING AUTODOCK VINA 
Docking simulation using AutoDock Vina is done by entering commands in the 
command promt (cmd) according to the installation location of the AutoDock Vina 
program and the work folder on the computer. After the running process is 
complete, in the folder there will be two files, namely 'result.txt' which is the result 
of a docking, it contained the value of affinity and 'out.pdbqt' which contained the 
ligand conformations after docking. The conformation can be separated by entering 
the split to cmd command. 
2.8 VISUALIZATION OF DOCKING RESULTS WITH PyMOL AND DSV 
PyMol is used to combine proteins that have been prepared with ligands from 
docking into a complex and stored in PDB format. The interaction formed between 
enzymes and ligands can be seen using DSV in 2D and 3D. 
2.9 DATA ANALYSIS 
Data that has been obtained from the docking process of chalcone analogue 
compounds using AutoDock Vina, obtained 9 affinity results for each compound, 
then each affinity with the smallest value was selected and then visualized using 
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PyMOL to combine enzymes that had been prepared with ligands. The docking 
results can be seen in the table, where the interaction between the ligand and its 
receptors will then be read using the DSV program both 2D and 3D. 
 
3. RESULTS AND DISCUSSION 
 
TABLE 2. 
Docking results of Chalcone and 5-Fluorouracil Analogue Compounds 
 
Compound 
Parameter  
Affinity  
(Bond Free 
Energy) 
(kcal/mol) 
Amount of 
Amino Acid 
Compatibility 
with 5-
fluorouracil 
Hidrogen Bond 
1 -10,1 5 Not Formed 
2 -9,7 6 Formed 
3 -9,6 9 Formed 
4 -7,0 4 Formed 
5 -7,2 2 Not Formed 
6 -5,6 1 Not Formed 
7 -7,0 3 Not Formed 
8 -8,3 6 Not Formed 
5-
fluorouracyl 
-5,1 - Formed 
 
 
FIGURE 1. Interaction of Protein Residues with Compound 1 
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FIGURE 2. Interaction of Protein Residues with Compound 2  
 
 
FIGURE 3. Interaction of Protein Residues with Compound 3  
 
FIGURE 4. Interaction of Protein Residues with Compound 4  
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FIGURE 5. Interaction of Protein Residues with Compound 5  
 
 
FIGURE 6. Interaction of Protein Residues with Compound 6 
 
FIGURE 7. Interaction of Protein Residues with Compound 7 
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FIGURE 8. Interaction of Protein Residues with Compound 8 
 
 
FIGURE 9. Interaction of protein residues with 5-fluorouracil  
 
 
FIGURE 10. Active Side of Protein 1T46 2D 
 
In this study, the steps taken were the selection of proteins used as receptors and 
the selection of ligands as compounds that would be tethered to the receptor. The 
crystallographic structure of a protein or 3D enzyme is provided on the website 
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www.pdb.org. In this study, the protein was used the crystallographic structure of 
the tyrosine kinase enzyme, which is from the Spodoptera frugiperda (GDP-ID 
1T46) with the resolution of 1.6 Å and it was released in 2004 by Mol et al. It is 
presented in Figure 1. Crystallography of 1T46 protein has water molecules, the 
water have to remove so as not to interfere with analysis and docking calculations 
because it is feared that there will be interaction between ligands and water 
molecules rather than receptors. In addition, the release of test ligands from proteins 
was carried out so that the test compounds used could be tethered to liver cancer cell 
receptors and replace test ligands. Most of the proteins provided by the site, 
unfortunately, it does not have hydrogen atoms, because of that hydrogen have to be 
added. Generally, hydrogen bonding was occured between ligands and receptors.  
Protein 1T46 has the active site Cys673, Cyc788, Cys809, Gly676, His790, Arg791, 
Ile789, Tyr672, Leu595, Leu644, Leu799, Val603, Val654, Val643, Val622, 
Val668, Ala621, Thr670, Lys623, Glu640, Asp810, and Phe811 shown in Appendix 
3 and located in coordinates x : 31,925, y : 25,893, and z : 35,098 in grid box 
settings. 
In this study 5 chalcone analogues were compounds that have been shown to have 
cytotoxic effects on HepG2 in vitro by Mai et al (2014), 3 compounds were taken 
from the lowest IC50 and 2 more compounds were selected from the highest IC50. 
Compound 1 has the lowest IC50 value of 8.60 µM, compound 2 with IC50 value of 
11.43 µM, compound 3 with IC50 13.08 µM and compound 4 and 5 has IC50 value> 
100 µM. 3 other compounds are modified compounds from compound 1 because 
they have the best cytotoxic activity. 
Based on the docking results, it was found that 5-fluorouracil (compound 9) has  
high affinity value compared to the 8 chalcone analog compounds tested which were 
-5.1 kcal / mol. 5-fluorouracil has 9 active sides formed after the docking process 
with receptors including Glu640, Lys623, Val654, Leu644, Cys809, Leu799, 
Ala621, Thr670, and Val603. 5-fluorouracil generally binds to the same amino acid 
with the active site of the 1T46 protein except Val668, with each bond in the form of 
van der Walls bond, hydrogen bond, pi-cation bond, pi-sigma bond, and pi-alkyl 
bond which can be seen in Figure 9. 
The docking results of all 8 compounds showed different affinity values. 
Compounds 1, 2, and 3 have the smallest affinity in a row, namely -10.1 kcal / mol, -
9.7 kcal / mol, and -9.6 kcal / mol, from all 8 chalcone analog compounds tested, so 
it can be said that the activity is better than the other 5 compounds, but it is still has 
to be seen by its interaction with proteins or receptors. The results of the docking of 
all 8 compounds showed different affinity values. Compounds 1, 2, and 3 have the 
smallest affinity of -10.1 kcal / mol, -9.7 kcal / mol, and -9.6 kcal / mol, 
respectively. From all 8 chalcone analogue compounds tested, so it can be said that 
the activity is better than the other 5 compounds, but it is still active since they have 
the interaction with proteins Tyr570, Tyr672, Asn680, Asp677, Asp572, Asp810, 
Asp820, Cys673, Cys788, Cys809, Leu595, Leu783, Leu799, Leu644, Aala621, 
Ala636, Thr670, Thr574, Val603, Val643, Val654, Val668, Lys623, Phe811, 
Gly676, Gly812, Ile808, Ile653, Ile571, Ile789, His790, Glu640, Glu635, Glu671, 
Ser639, Pro573, Arg791, Arg815, dan Arg796. However, not all of these protein 
residues become the active side of 1T46. 
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CONCLUSION 
Chalcone compounds 1, 2, and 3 showed affinity of -10,1 kcal / mol, -9,7 kcal / 
mol, and -9,6 kcal / mol, respectively. After 2D visualization there were 10 residues 
that interacted with the sites active protein 1T46, according to Mai et al (2014) this 
compound has the potential as an inhibitor against liver cancer (HepG2). While 
compound 8 which is a modified compound can be used as a reference if you want 
to be directed as an inhibitor for liver cancer (HepG2), because it has an affinity of -
8.3 kcal / mol after 2D visualization There are 7 residues that interact with the active 
side of 1T46 protein and 6 acid residues amino has similarities with 5-fluorouracil. 
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